Printer Friendly

VILLAFANA ANNOUNCES ATS MEDICAL, INC. YEAR END RESULTS

 MINNEAPOLIS, Feb. 11 /PRNewswire/ -- ATS Medical, Inc. (NASDAQ-NMS: ATSI) today reported net sales of $634,226 for the year ended Dec. 31, 1992, representing initial sales of the ATS Open Pivot Bileaflet(TM) valve for human implant in international markets. For the fourth quarter of 1992, the company reported net sales of $409,366, compared to no sales in 1991.
 Manny Villafana, chairman and chief executive officer of ATS Medical, Inc., expressed the company's satisfaction with the introduction of the valve. "During 1992, we successfully introduced the valve for initial human implants in the developed European markets and other international markets," commented Villafana. "We recently began manufacturing the remaining sizes of the valve and expect to have all seven sizes available for sale by the end of the first quarter of 1993," added Villafana.
 Villafana also reported that the initial performance reports on the valve continue to be encouraging. The valve has exhibited very low gradients and low regurgitation in clinical performance. Preliminary reports also indicate that the noise generated by the valve in operation may be significantly lower than competitive mechanical valves.
 ATS Medical, Inc. manufactures and markets a new pyrolytic carbon bileaflet mechanical heart valve. The company's common stock is traded on the NASDAQ National Market System under the symbol ATSI.
 ATS MEDICAL, INC.
 CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS
 Three Months Ended Year Ended
 12/31/92 12/31/91 12/31/92 12/31/91
 Net sales $409,366 $0 $634,226 $0
 Cost of goods sold 277,089 0 430,648 0
 Gross profit 132,277 0 203,578 0
 Research, development
 and engineering
 expenses 1,088,179 228,343 2,670,773 963,849
 Selling, general and
 administrative expenses 595,560 538,120 2,246,259 1,971,108
 Loss from continuing
 operations $(1,500,340) $(691,815) (4,538,190) (2,607,268)
 Loss per share from
 continuing operations $(.15) $(.08) $(.48) $(.30)
 Weighted average
 number of shares
 outstanding 10,023,664 8,925,223 9,404,587 8,771,632
 -0- 2/11/93
 /CONTACT: Manny Villafana, chairman/CEO; Richard Kramp, president/COO; or Jack Jungbauer, treasurer/CFO; all of ATS Medical, 612-553-7736/
 (ATSI)


CO: ATS Medical, Inc. ST: Minnesota IN: MTC SU: ERN

KH -- MN043 -- 5889 02/11/93 16:53 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 11, 1993
Words:380
Previous Article:ACCOUNTING CHANGES, REORGANIZATION COSTS RESULT IN LOWER GRACO NET EARNINGS
Next Article:XATA CORPORATION REPORTS FIRST QUARTER RESULTS
Topics:


Related Articles
ATS MEDICAL ANNOUNCES SECOND QUARTER RESULTS
ATS MEDICAL, INC. ANNOUNCES SUCCESSFUL FINANCING AND THIRD QUARTER RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. FIRST QUARTER RESULTS
VILLAFANA ANNOUNCES ATS MEDICAL, INC. SECOND QUARTER RESULTS
ATS MEDICAL, INC. ANNOUNCES RECORD FOURTH QUARTER RESULTS AND CONTINUED CLINICAL SUCCESS WITH ITS HEART VALVE
ATS MEDICAL ANNOUNCES FINANCING AND LOWERING OF CAPITAL REQUIREMENTS
MANNY VILLAFANA ANNOUNCES ATS MEDICAL, INC. AUDITED YEAR END RESULTS
MANNY VILLAFANA ANNOUNCES ATS MEDICAL, INC. FIRST QUARTER RESULTS
MANNY VILLAFANA ANNOUNCES ATS MEDICAL, INC. RECORD FOURTH QUARTER RESULTS
MANNY VILLAFANA ANNOUNCES ATS MEDICAL, INC. RECORD YEAR END RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters